Investors

EQL Pharma develops, sells and markets medicines with a focus on niche products having no patent protection. The company currently has a smaller portfolio on the market and an extensive pipeline of unique medicines. EQL Pharma strives to maintain an open and proactive dialogue with current and potential shareholders and to give the market and society a good insight into and understanding of our business.